XML 22 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash Flows From Operating Activities:    
Net loss $ (24,449) $ (12,580)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 478 163
Share-based compensation 5,356 2,237
Common shares issued for services 239 0
Product line exit expense 747 0
Debt forgiveness income 0 (417)
Gain on sale of assets (27) 0
Warranty provision 10 30
Inventory write-offs 0 (68)
Software impairment charge 170 0
Change in contingent liability (23) 0
Non-cash lease expense 88 122
Non-cash interest expense 0 2
Provision for doubtful accounts 123 10
Changes in assets and liabilities:    
Accounts receivable (2,111) (1,686)
Inventories 559 (343)
Prepaid expenses and other current assets (109) (508)
Accounts payable 546 825
Operating lease liability (94) (128)
Customer deposits 41 (342)
Accrued liabilities and other (54) 493
Warranty settlement 38 4
Deferred revenue 249 (1)
Net cash used in operating activities (18,223) (12,187)
Cash Flows From Investing Activities:    
Purchase of short-term investments (55,014) (34,980)
Proceeds from maturities of short-term investments 50,005 10,000
Capital expenditures for property and equipment (995) (249)
Business acquisition 0 (210)
Proceeds from long-term deposits 4 0
Net cash used in investing activities (6,937) (26,111)
Cash Flows From Financing Activities:    
Sale of common stock and warrants 0 12,400
Offering costs paid on sale of common stock and warrants 0 (733)
Proceeds from exercise of warrants 12,047 26,191
Offering costs paid on exercise of warrants 0 (1,016)
Proceeds from exercise of stock options 1,678 705
Proceeds from bank note 0 414
Repayment of debt (275) 0
Net cash provided by financing activities 13,450 37,961
Net decrease in cash and cash equivalents (11,710) (337)
Cash and cash equivalents, beginning of period 16,647 16,984
Cash and cash equivalents, end of period 4,937 16,647
Supplemental Disclosure of Non-Cash Investing    
Business acquisition liability 0 298
Business acquisition cost in deferred revenue 0 15
Change in unrealized gain on short-term investments (21) 15
Patents and Trademarks [Member]    
Cash Flows From Investing Activities:    
Payments for intangible assets (187) (129)
Intangibles Other than Patents and Trademarks [Member]    
Cash Flows From Investing Activities:    
Payments for intangible assets $ (750) $ (543)